Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast

Pharmaceutical Research

Volumn 28, Issue 8, 2011, Pages 1895-1904

  Kundoor, Vipra ^a,b   Dalby, Richard N ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

deposition pattern; droplet size; formulation; nasal spray; spray pump design; viscosity

Indexed keywords

FLUTICASONE PROPIONATE; NOSE SPRAY; TRIAMCINOLONE ACETONIDE; WATER;

ARTICLE; COMPUTER PROGRAM; DRUG FORMULATION; GEL; IMAGE ANALYSIS; MEDICAL PHOTOGRAPHY; PRIORITY JOURNAL; PUMP DESIGN; SIMULATION; VISCOSITY;

ADMINISTRATION, INTRANASAL; CHEMISTRY, PHARMACEUTICAL; HUMANS; MODELS, ANATOMIC; NASAL SPRAYS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; TISSUE DISTRIBUTION; VISCOSITY;

EID: 79961166137     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0417-6     Document Type: Article

References (16)

1. P Arora S Sharma S Garg 2002 Permeability issues in nasal drug delivery Drug Discov Today 7 18 967 975 12546871 10.1016/S1359-6446(02)02452-2 1:CAS:528:DC%2BD38XotVCru7c%3D (Pubitemid 35286901)
2. JD Suman BL Laube R Dalby 1999 Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump Pharm Res 16 10 1648 1652 10554112 10.1023/A:1011933410898 1:CAS:528:DyaK1MXntVOhu7w%3D (Pubitemid 29510567)
3. SP Newman KP Steed JG Hardy IR Wilding G Hooper RA Sparrow 1994 The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques J Pharm Pharmacol 46 657 660 7815279 10.1111/j.2042-7158.1994.tb03877.x 1:CAS:528:DyaK2cXlvVOjur8%3D (Pubitemid 24249354)
4. MT Vidgren H Kublik 1998 Nasal delivery systems and their effect on deposition and absorption Adv Drug Deliv Rev 29 157 177 10837586 10.1016/S0169-409X(97)00067-7 (Pubitemid 28044092)
5. Food Drug Administration. U.S. FDA draft guidance for industry: bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action. Rockville: US Food and Drug Administration; 2003.
6. AS Harris E Svensson ZG Wagner S Lethagen IM Nilsson 1988 Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin J Pharm Sci 77 405 408 3411462 10.1002/jps.2600770510 1:CAS:528:DyaL1cXkt1Omtrc%3D (Pubitemid 19080860)
7. YS Cheng TD Holmes J Gao RA Guilmette S Li Y Surakitbanharn, et al. 2001 Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway J Aerosol Med 14 267 280 11681658 10.1089/08942680152484199 1:CAS:528:DC%2BD3MXmsVyitbY%3D (Pubitemid 32744358)
8. MY Foo Y Cheng W Su MD Donovan 2007 The influence of spray properties on intranasal deposition J Aerosol Med 20 4 495 508 18158721 10.1089/jam.2007.0638 1:CAS:528:DC%2BD1cXhtFCqtQ%3D%3D
9. JS Kimbell RA Segal B Asgharian BA Wong JD Schroeter JP Southhall, et al. 2007 Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages J Aerosol Med 20 59 74 17388754 10.1089/jam.2006.0531 (Pubitemid 46542937)
10. V Kundoor RN Dalby 2010 Assessment of nasal spray deposition in a silicone human nose model using a color based method Pharm Res 27 1 30 36 19902337 10.1007/s11095-009-0002-4 1:CAS:528:DC%2BD1MXhtlynt7bN
11. Poochikian G, Shah V. Pharmaceutical quality assessment system (PQAS): science and risk managed approaches for inhalation drug products. In: Dalby RN, Byron PR, Peart J, Suman JD, editors. Respiratory Drug Delivery 2006 (Book 1, ISBN 1-930114-95-8). Davis Healthcare, River Grove: Illinois; 2006;151-8.
12. Pharmaceutical cGMPS for the 21st century-a risk-based approach. Rockville: US Food and Drug Administration; 2004.
13. Doughty DV, Vibbert C, Bollinger ME, Kewalramani A, Dalby RN. Automated Actuation of Nasal Spray Products: Determination and Comparison of Adult and Pediatric Settings. Drug Dev Ind Pharm. 2010;37(3):359-366.
14. MS Benninger JA Hadley JD Osguthorpe BF Marple DA Leopold MJ Derebery, et al. 2004 Techniques of intranasal steroid use Otolaryngol Head Neck Surg 130 5 24 14726906 10.1016/j.otohns.2003.10.007 (Pubitemid 38113911)
15. Y Guo B Laube R Dalby 2005 The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model Pharm Res 22 11 1871 1878 16091994 10.1007/s11095-005-7391-9 1:CAS:528:DC%2BD2MXhtFChs7nM (Pubitemid 41504340)
16. J Pennington P Pandey H Tat J Willson B Donovan 2008 Spray pattern and droplet size analyses for high-shear viscosity determination of aqueous suspension corticosteroid nasal sprays Drug Dev Ind Pharm 34 923 929 18800252 10.1080/03639040802149046 1:CAS:528:DC%2BD1cXhtFais7%2FN